TREATMENT OF ADULT ACUTE MYELOBLASTIC-LEUKEMIA (AML) UNRESPONSIVE TO OR RELAPSING FOLLOWING ARA-C THERAPY

被引：0
|
作者：
RAAB, SO
SHAW, MT
机构：
[1] UNIV ARKANSAS,LITTLE ROCK,AR 72201
[2] YALE UNIV,NEW HAVEN,CT 06510
来源：
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH | 1977年 / 18卷 / MAR期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：49 / 49
页数：1
相关论文
共 50 条
  • [41] Salvage therapy with ARA-C and gemtuzumab ozogamicin in AML patients relapsing after stem cell transplantation
    Maya Koren-Michowitz
    Hannah Maayan
    Arie Apel
    Noga Shem-Tov
    Ronit Yerushalmi
    Yulia Volchek
    Abraham Avigdor
    Avichai Shimoni
    Arnon Nagler
    Annals of Hematology, 2015, 94 : 375 - 378
  • [42] ACUTE MYELOBLASTIC-LEUKEMIA FOLLOWING CHEMOTHERAPY FOR MYCOSIS-FUNGOIDES
    WADDELL, CC
    ZUBLER, MA
    GORE, WS
    ARCHIVES OF DERMATOLOGY, 1982, 118 (03) : 179 - 182
  • [43] Amonafide and ara-C treatment for secondary acute myeloid leukemia (sAML)
    Erba, H. P.
    Rizzieri, D. A.
    O'Donnell, M. R.
    Lundberg, A. S.
    Ajami, A. M.
    Rampersad, A. D.
    Capizzi, R. L.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [44] Salvage therapy with ARA-C and gemtuzumab ozogamicin in AML patients relapsing after stem cell transplantation
    Koren-Michowitz, Maya
    Maayan, Hannah
    Apel, Arie
    Shem-Tov, Noga
    Yerushalmi, Ronit
    Volchek, Yulia
    Avigdor, Abraham
    Shimoni, Avichai
    Nagler, Arnon
    ANNALS OF HEMATOLOGY, 2015, 94 (03) : 375 - 378
  • [45] ACQUIRED ISOLATED F-X DEFICIENCY IN ACUTE MYELOBLASTIC-LEUKEMIA (AML)
    PABINGER, I
    BETTELHEIM, P
    HINTERBERGER, W
    KORNINGER, C
    LECHNER, K
    NEUMANN, E
    NIESSNER, H
    THROMBOSIS AND HAEMOSTASIS, 1985, 54 (01) : 256 - 256
  • [46] CLOFARABINE IN COMBINATION WITH CYTARABINE (ARA-C) FOR TREATMENT OF RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA IN ADULT PATIENTS
    Malato, A.
    Santoro, A.
    Magrin, S.
    Felice, R.
    Turri, D.
    Di Bella, R.
    Salemi, D.
    Acquaviva, F.
    Scime, R.
    Fabbiano, F.
    HAEMATOLOGICA, 2012, 97 : 502 - 503
  • [47] THE CONTRIBUTION OF BLAST CELL PROPERTIES TO OUTCOME VARIATION IN ACUTE MYELOBLASTIC-LEUKEMIA (AML)
    MCCULLOCH, EA
    CURTIS, JE
    MESSNER, HA
    SENN, JS
    GERMANSON, TP
    BLOOD, 1982, 59 (03) : 601 - 608
  • [48] CORRELATION OF SURFACE MARKER ANALYSIS AND MORPHOLOGICAL DIAGNOSIS IN ACUTE MYELOBLASTIC-LEUKEMIA (AML)
    SEIBTJUNG, H
    PAULSEN, M
    LUDWIG, WD
    HERRMANN, F
    KAROW, J
    RUHL, H
    BLUT, 1985, 51 (03): : 239 - 239
  • [49] Interim analysis of cytarabine (ara-C) and cladribine (2-CDA) combination therapy in acute myeloid leukemia (AML).
    Radomski, KM
    Gandhi, V
    Srivastava, DK
    Razzouk, BI
    Behm, FG
    Plunkett, W
    Pui, CH
    Rubnitz, JE
    Ribeiro, RC
    BLOOD, 2000, 96 (11) : 327A - 327A
  • [50] CLINICAL-PHARMACOLOGY OF INTERMEDIATE DOSE ARA-C (ID ARA-C) IN THE TREATMENT OF ACUTE MYELOID-LEUKEMIA IN RELAPSE
    VANPROOYEN, HC
    DEKKER, AW
    PUNT, K
    BRITISH JOURNAL OF HAEMATOLOGY, 1985, 60 (02) : 355 - 356
12345